Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TOR complex 1 (TORC1), an oligomer of the
mTOR
(
mammalian target of rapamycin
) protein kinase, its substrate binding subunit raptor, and the polypeptide Lst8/GbetaL, controls cell growth in all eukaryotes in response to nutrient availability and in metazoans to insulin and growth factors, energy status, and stress conditions. This review focuses on the biochemical mechanisms that regulate mTORC1 kinase activity, with special emphasis on mTORC1 regulation by amino acids. The dominant positive regulator of mTORC1 is the GTP-charged form of the ras-like GTPase
Rheb
. Insulin, growth factors, and a variety of cellular stressors regulate mTORC1 by controlling
Rheb
GTP charging through modulating the activity of the tuberous sclerosis complex, the
Rheb
GTPase activating protein. In contrast, amino acids, especially leucine, regulate mTORC1 by controlling the ability of
Rheb
-GTP to activate mTORC1.
Rheb
binds directly to
mTOR
, an interaction that appears to be essential for mTORC1 activation. In addition,
Rheb
-GTP stimulates phospholipase D1 to generate phosphatidic acid, a positive effector of mTORC1 activation, and binds to the
mTOR
inhibitor FKBP38, to displace it from
mTOR
. The contribution of
Rheb
's regulation of PL-D1 and FKBP38 to mTORC1 activation, relative to
Rheb
's direct binding to
mTOR
, remains to be fully defined. The rag GTPases, functioning as obligatory heterodimers, are also required for amino acid regulation of mTORC1. As with amino acid deficiency, however, the inhibitory effect of rag depletion on mTORC1 can be overcome by
Rheb
overexpression, whereas
Rheb
depletion obviates rag's ability to activate mTORC1. The rag heterodimer interacts directly with mTORC1 and may direct mTORC1 to the
Rheb
-containing vesicular compartment in response to amino acid sufficiency, enabling
Rheb
-GTP activation of mTORC1. The type III phosphatidylinositol kinase also participates in amino acid-dependent mTORC1 activation, although the site of action of its product, 3'OH-phosphatidylinositol, in this process is unclear.
...
PMID:Amino acid regulation of TOR complex 1. 1876 78
The mechanisms of action of farnesyltransferase inhibitors (FTIs) involve
Rheb
and the phosphatidylinositide 3-kinase/Akt/
mammalian target of rapamycin
(
mTOR
) pathway.
mTOR
in particular plays a key role in the regulation of autophagy. Collectively, the literature suggests that FTIs very likely induce autophagy, but thus far there have been no reports that FTIs affect this process relevant to cancer cell biology. We hypothesized that FTIs can induce autophagy. In this study, we found that the FTIs manumycin A, FTI-276, and lonafarnib induced autophagy in two human cancer cell lines. We also found that neither inhibition of apoptosis with a pan-caspase inhibitor nor inhibition of autophagy increased the number of clones of lonafarnib-treated U2OS osteosarcoma cells that formed in soft agar. Although whether autophagy is a cell death or cell survival mechanism after FTI treatment remains unresolved, our data show that cancer cells apparently can shift between apoptosis and autophagy once they are committed to die after FTI treatment.
...
PMID:Autophagy induced by farnesyltransferase inhibitors in cancer cells. 1876 23
Muscle growth is associated with an activation of the
mTOR
signaling pathway and satellite cell regulators. The purpose of this study was to determine whether 17 selected genes associated with
mTOR
/muscle protein synthesis and the satellite cells/myogenic program are differentially expressed in young and older human skeletal muscle at rest and in response to a potent anabolic stimulus [resistance exercise + essential amino acid ingestion (RE+EAA)]. Twelve male subjects (6 young, 6 old) completed a bout of heavy resistance exercise. Muscle biopsies were obtained before and at 3 and 6 h post RE+EAA. Subjects ingested leucine-enriched essential amino acids at 1 h postexercise. mRNA expression was determined using qRT-PCR. At rest, hVps34 mRNA was elevated in the older subjects (P < 0.05) while there was a tendency for levels of myoD, myogenin, and TSC2 mRNA to be higher than young. The anabolic stimulus (RE+EAA) altered mRNAs associated with
mTOR
regulation. Notably, REDD2 decreased in both age groups (P < 0.05) but the expression of
Rheb
mRNA increased only in the young. Finally, cMyc mRNA was elevated (P < 0.05) in both young and old at 6 h post RE+EAA. Furthermore, RE+EAA also increased expression of several mRNAs associated with satellite function in the young (P < 0.05), while expression of these mRNAs did not change in the old. We conclude that several anabolic genes in muscle are more responsive in young men post RE+EAA. Our data provide new insights into the regulation of genes important for transcription and translation in young and old human skeletal muscle post RE+EAA.
...
PMID:Expression of growth-related genes in young and older human skeletal muscle following an acute stimulation of protein synthesis. 1878 87
The development of polarized hippocampal neurons with a single axon and multiple dendrites depends on the activity of phosphoinositide 3-kinase (PI3K) and the GTPase Rap1B. Here we show that PI3K regulates axon specification and elongation through the GTPase
Rheb
and its target
mammalian target of rapamycin
(
mTOR
). Overexpression of
Rheb
induces the formation of multiple axons, whereas its suppression by RNA interference blocks axon specification.
mTOR
is a central regulator of translation that phosphorylates eIF4E-binding proteins like 4E-BP1. Axon formation was suppressed by inhibition of
mTOR
and expression of
mTOR
-insensitive 4E-BP1 mutants. Inhibition of PI3K or
mTOR
reduced the level of Rap1B, which acts downstream of
Rheb
and
mTOR
. The ubiquitin E3 ligase Smurf2 mediates the restriction of Rap1B by initiating its degradation. Suppression of Smruf2 by RNA interference is able to compensate the loss of
Rheb
. These results indicate that the
mTOR
pathway is required to counteract the Smurf2-initiated degradation of Rap1B during the establishment of neuronal polarity.
...
PMID:Rheb and mTOR regulate neuronal polarity through Rap1B. 1884 93
The
mammalian target of rapamycin
(
mTOR
) assembles a signaling network that transduces nutrient signals and various other stimuli to regulate a wide range of cellular functions. Of the two distinct
mTOR
complexes, mTORC1 is under the control of the TSC-
Rheb
pathway, which serves as an integrator of multiple upstream signals. A lipid signaling cascade involving phospholipase D (PLD) and phosphatidic acid (PA) has also been known to mediate mitogenic signals upstream of mTORC1. A new study now reveals a direct connection between these two regulatory pathways and demonstrates that PLD1 is an effector of
Rheb
in the activation of mTORC1. A novel role of PLD as a nutrient sensor has also been suggested. In this extra-view, we discuss the emerging importance of PA and PLD in the mTORC1 signaling network and the biological processes it governs. We also consider the implications from several recent findings and propose mechanistic models of PLD-
mTOR
signaling to be tested in the near future.
...
PMID:mTOR signaling: PLD takes center stage. 1892 11
Cells sense nutrients present in the extracellular environment and modulate the activities of intracellular signaling systems in response to nutrient availability. This study demonstrates that RalA and its activator RalGDS participate in nutrient sensing and are indispensable for activation of
mammalian target of rapamycin
complex 1 (mTORC1) induced by extracellular nutrients. Knockdown of RalA or RalGDS abolished amino acid- and glucose-induced mTORC1 activation, as judged by phosphorylation of S6 kinase and eukaryotic translation initiation factor 4E-binding protein 1. The amount of GTP-bound RalA increased in response to increased amino acid availability. In addition, RalA knockdown suppressed
Rheb
-induced S6 kinase phosphorylation, and the constitutively active form of RalA induced mTORC1 activation in the absence of
Rheb
. These results collectively suggest that RalGDS and RalA act downstream of
Rheb
and that RalA activation is a crucial step in nutrient-induced mTORC1 activation.
...
PMID:RalA functions as an indispensable signal mediator for the nutrient-sensing system. 1894 69
The signaling pathways that are regulated by sphingosine-1-phosphate (S1P) and
mammalian target of rapamycin
(
mTOR
) modulate cell growth, mitogenesis and apoptosis in various cell types and are of major interest for the development of new cancer therapeutics. Previous reports show that S1P can cross-activate the
mTOR
pathway although the mechanisms that connect both pathways are still unknown. We found that S1P-treatment activates
mTOR
in several cancer cell lines and primary cells. The activation was independent of ERK, Akt and PI3-kinase, but instead was mediated by the E3 ubiquitin ligase Protein Associated with Myc (PAM). Increased intracellular PAM concentrations facilitated S1P- and insulin-induced
mTOR
activation as well as p70S6K and 4EBP1 phosphorylation while genetic deletion of PAM decreased S1P- and insulin-induced
mTOR
activation. PAM activated by facilitating the GDP/GTP-exchange of
Rheb
which is an activator of
mTOR
. In conclusion we show that PAM is a novel regulator of the
mTOR
pathway and that PAM may directly activate
Rheb
as a guanosine exchange factor (GEF).
...
PMID:Sphingosine-1-phosphate induced mTOR-activation is mediated by the E3-ubiquitin ligase PAM. 1900 Jul 55
The stimulatory effect of insulin on protein synthesis is due to its ability to activate various translation factors. We now show that insulin can increase protein synthesis capacity also by translational activation of TOP mRNAs encoding various components of the translation machinery. This translational activation involves the tuberous sclerosis complex (TSC), as the knockout of TSC1 or TSC2 rescues TOP mRNAs from translational repression in mitotically arrested cells. Similar results were obtained upon overexpression of
Rheb
, an immediate TSC1-TSC2 target. The role of
mTOR
, a downstream effector of
Rheb
, in translational control of TOP mRNAs has been extensively studied, albeit with conflicting results. Even though rapamycin fully blocks
mTOR
complex 1 (mTORC1) kinase activity, the response of TOP mRNAs to this drug varies from complete resistance to high sensitivity. Here we show that
mTOR
knockdown blunts the translation efficiency of TOP mRNAs in insulin-treated cells, thus unequivocally establishing a role for
mTOR
in this mode of regulation. However, knockout of the raptor or rictor gene has only a slight effect on the translation efficiency of these mRNAs, implying that
mTOR
exerts its effect on TOP mRNAs through a novel pathway with a minor, if any, contribution of the canonical
mTOR
complexes mTORC1 and mTORC2. This conclusion is further supported by the observation that raptor knockout renders the translation of TOP mRNAs rapamycin hypersensitive.
...
PMID:The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner. 1904 68
Lymphangioleiomyomatosis is a rare and progressive lung cystic disease, caused by the infiltration of lung parenchyma by mesenchymal cells characterized by co-expression of contractile proteins and melanocytic markers. The pathogenesis of lymphangioleiomyomatosis is determined by mutations affecting tuberous sclerosis complex (TSC) genes, with eventual deregulation of the
Rheb
/
mTOR
/p70S6K pathway, and the potential therapeutic activity of
mTOR
inhibitors is currently under investigation. To better understand the molecular mechanisms involved in the pathogenesis of lymphangioleiomyomatosis, we investigated the expression of cathepsin-k (a papain-like cysteine protease with high matrix-degrading activity). The rationale of this choice was based on the recent demonstration that
mTOR
inhibitors can regulate major functional activities of osteoclasts, including the expression of cathepsin-k. The immunohistochemical study included 12 cases of lymphangioleiomyomatosis. Twelve angiomyolipomas and several lung diseases (sarcoidosis, organizing pneumonia, usual interstitial pneumonia, emphysema) were investigated as controls. In all lymphangioleiomyomatosis cases, strong cathepsin-k immunoreactivity was demonstrated, restricted to lymphangioleiomyomatosis cells. Similar expression levels were observed in renal angiomyolipomas. These observations extend the knowledge regarding the immunophenotypic profile of lymphangioleiomyomatosis cells, and provide a useful new marker for diagnosis in difficult cases (eg, in small transbronchial biopsies). The strong expression of such a potent papain-like cysteine protease in lymphangioleiomyomatosis cells can significantly contribute to the progressive remodelling of lung parenchyma observed in this deadly disease, with eventual formation of lung cysts. It is possible to speculate that
mTOR
inhibitors may exert part of their action by limiting the destructive remodelling of lung structure.
...
PMID:Cathepsin-k expression in pulmonary lymphangioleiomyomatosis. 1906 Aug 45
Farnesyltransferase inhibitors (FTIs) were designed to block the action of Ras oncoproteins which depend on posttranslational modification by adding a farnesyl isoprenoid membrane anchor. However, off-target actions are believed to account for most of their antitumor activity. We recently reported the induction of autophagy in cancer cells in a dose-dependent manner by FTIs. We observed similar results of autophagy in a panel of tumor cell lines for the three FTIs tested. Therefore, the induction of autophagy is very likely a pharmacological class effect of inhibition of farnesyltransferase. In this addendum, we discuss the possible mechanisms underlying the induction of autophagy by FTIs, including reactive oxygen species-, DNA damage- and Ras-mediated pathways as alternatives to
Rheb
-mediated regulation of
mTOR
and autophagy.
...
PMID:Farnesyltransferase inhibitors-induced autophagy: alternative mechanisms? 1906 66
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>